Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Only 12 Evaluable Patients at 450 days 67% CR !!!!!!

<< Previous

Bullboard Posts

Next >>

Comment by TimboBagginson Apr 26, 2023 8:32pm

145 Views

Post# 35415985

RE:RE:RE:Only 12 Evaluable Patients at 450 days 67% CR !!!!!!

DJDawg wrote: That is so strange. I feel like the AUA poster will be needed to clean up the data presentation.
12 evaluable makes no sense when they said 29 evaluable before.

If only the company could release news that was coherent and straight forward. We're always left trying to make sense of this garbage. Why can't they explain why the numbers dropped???? Yeah F us I guess.

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle